SEC Comment Letter 0000000000-25-001954 to AVAI BIO, INC. (AVAI)
AVAI BIO, INC.
Date: Feb. 19, 2025 · CIK: 0001740797 · Accession: 0000000000-25-001954
AI Filing Summary & Sentiment
File numbers found in text: 333-225433
Letter
February 19, 2025 Vitalis Racius Chief Financial Officer Avant Technologies c/o Eastbiz.com, Inc. 5348 Vegas Drive Las Vegas, NV 89108 Re:Avant Technologies Forms 10-K and 10-K/A for the Year Ended March 31, 2024 File No. 333-225433 Dear Vitalis Racius: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Technology cc:Chris Winter, CEO
Show Raw Text
February 19, 2025
Vitalis Racius
Chief Financial Officer
Avant Technologies
c/o Eastbiz.com, Inc.
5348 Vegas Drive
Las Vegas, NV 89108
Re:Avant Technologies
Forms 10-K and 10-K/A for the Year Ended March 31, 2024
File No. 333-225433
Dear Vitalis Racius:
We have completed our review of your filing. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Technology
cc:Chris Winter, CEO